Name: VCYT Income Statement - Veracyte Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

VCYT - Veracyte, Inc.

USD | NASDAQ | Healthcare

VCYT Income Statement - Veracyte Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	139.1	140.6	131.9	130.2	114.5	118.6	115.9	114.4	96.8	98.2	90.1	90.3	82.4	80.3	75.6	72.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenues
Revenues	541.7	517.1	445.8	361.1	296.5	219.5	117.5	120.4	92.0	72.0	65.1	49.5	38.2	21.9	11.6	2.6
Cost of Revenue	-	-	-	-	-	-	-	36.1	33.1	28.2	25.5	21.5	16.6	12.6	7.6	2.9
Gross Profit	-	-	-	-	-	-	-	84.3	58.9	43.8	39.6	28.0	21.6	9.3	4.0	(0.3)
Operating Expenses
Research & Development	80.2	70.8	69.3	57.3	40.6	29.8	17.2	14.9	14.8	13.9	15.3	12.8	9.8	7.8	6.6
Operating Income
Operating Income	77.5	57.8	16.1	(85.8)	(41.1)	(81.9)	(35.4)	(15.1)	(22.2)	(26.5)	(28.8)	(33.5)	(29.0)	(23.2)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	0.0
Tax & Net
Income Tax Expense	2.7	1.8	1.6	(2.2)	0.1	(6.1)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Per Share
EPS Basic	1.11	0.84	0.32	(1.02)	(0.51)	(1.11)	(0.66)	(0.27)	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	-	79.2	39.6	(58.6)	(15.2)	(62.3)	(27.4)	(11.0)	(18.3)	(22.7)	(25.3)	(31.2)	(27.8)	(22.2)	(18.2)	(14.7)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	27.1	20.8	16.0	16.3	17.7	19.3	17.6	16.5	16.0	18.7	13.3	12.5	12.8	11.3	10.8	9.4	9.2	10.3	8.0	6.2	5.3	4.6	4.0	4.2	4.4	4.4	3.6	3.3	3.4	3.1	3.4	4.6	3.7	3.2	3.0	3.6	4.0	3.6	4.0	4.3
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	27.2	25.9	24.5	25.3	24.5	24.8	22.6	24.2	23.8	25.3	24.3	25.8	26.1	24.1	25.7	24.0	23.8
General & Administrative	23.7	17.4	27.3	32.3	33.8	26.9	25.7	31.7	26.2	23.8	16.3	25.0	21.1	14.9	17.6	19.8	20.9
Depreciation & Amortization	5.4	-	-	-	5.4	-	-	-	5.6	-	-	-	6.7	-	-	-
Amortization of Intangibles	3.3	3.4	3.3	3.3	3.2	3.5	3.8	3.8	3.7	4.7	5.3	5.3	5.3	5.3	5.2	5.4	5.5
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	78.5	64.8	68.3	95.0	76.6	74.6	67.0	73.3	67.1	69.3	89.4	63.9	92.9	(35.1)	85.3	83.6

Operating Income
Operating Income	22.6	37.2	22.9	(5.3)	2.9	4.2	12.0	4.6	(4.7)	(35.5)	(31.7)	(8.1)	(10.5)	(5.4)	(9.7)	(10.7)	(15.2)	(12.3)	(16.7)	(7.5)	(45.4)	(8.1)	(4.1)	(11.1)	(12.2)	(8.2)	(1.8)	(3.1)	(2.1)	(3.1)	(4.3)	(5.9)	(9.0)	(6.0)	(6.4)	(6.6)	(7.5)	(3.7)	(4.9)	(10.5)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	7.3	3.4	(4.1)	6.5	4.5	(0.7)	4.8	2.8	2.7	5.0	2.0	(0.2)	2.4	2.0	0.8	1.1	0.8
Pre-Tax Income	30.0	40.6	18.9	1.3	7.4	3.4	16.8	7.4	(1.9)	(30.5)	(29.8)	(8.3)	(8.1)	(3.4)	(8.9)	(9.6)

Tax & Net
Income Tax Expense	1.3	(0.5)	(0.2)	2.2	0.4	(1.7)	1.7	1.6	(0.0)	(2.2)	(0.2)	0.1	0.0	0.4	(0.2)	(0.1)	(0.0)	(0.8)	(1.4)	(0.2)	(3.8)	0.0	0.0	0.0	0.0	-	0.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	28.7	41.1	19.1	(1.0)	7.0	5.1	15.2	5.7	(1.9)	(28.3)	(29.6)	(8.4)	(8.1)	(3.8)	(8.7)	(9.5)	(14.5)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	28.7	41.1	19.1	(1.0)	7.0	5.1	15.2	5.7	(1.9)	(28.3)	(29.6)	(8.4)	(8.1)	(3.8)	(8.7)	(9.5)	(14.5)
Net Income Attributable To Parent	28.7	41.1	19.1	(1.0)	7.0	5.1	15.2	5.7	(1.9)	(28.3)	(29.6)	(8.4)	(8.1)	(3.8)	(8.7)	(9.5)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	28.7	41.1	19.1	(1.0)	7.0	5.1	15.2	5.7	(1.9)	(28.3)	(29.6)	(8.4)	(8.1)	(3.8)	(8.7)

Per Share
EPS Basic	0.36	-	0.24	(0.01)	0.09	-	0.20	0.07	(0.02)	-	(0.41)	(0.12)	(0.11)	-	(0.12)	(0.13)	(0.20)	-	(0.20)	(0.13)	(0.66)	-	(0.08)	(0.22)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	0.35	-	0.24	(0.01)	0.09	-	0.19	0.07	(0.02)	-	(0.41)	(0.12)	(0.11)	-	(0.12)	(0.13)	(0.20)	-
Shares Basic	79.5	-	78.7	78.4	78.0	-	77.0	76.5	74.8	-	72.8	72.5	72.2	-	71.7	71.5	71.2	-
Shares Diluted	81.3	-	79.7	78.4	80.1	-	78.5	77.2	74.8	-	72.8	72.5	72.2	-	71.7	71.5	71.2	-

Supplementary Data
EBITDA	28.1	-	-	-	8.3	-	-	-	0.9	-	-	-	(3.8)	-	-	-	(8.7)	-	-	-	(42.9)	-	-	-	(10.2)	-	-	-	(1.1)	-	-	-	(8.0)	-	-	-	(6.6)	-	-	-
EBIT	22.6	37.2	22.9	(5.3)	2.9	4.2	12.0	4.6	(4.7)	(35.5)	(31.7)	(8.1)	(10.5)	(5.4)	(9.7)	(10.7)	(15.2)	(12.3)	(16.7)